BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3724938)

  • 1. [Detection of fibrinolysis in chronic subdural hematoma].
    Trappe A; Hafter R; Wendt P; Graeff H; Blümel G
    Neurochirurgia (Stuttg); 1986 May; 29(3):78-82. PubMed ID: 3724938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma.
    Ito H; Yamamoto S; Komai T; Mizukoshi H
    J Neurosurg; 1976 Jul; 45(1):26-31. PubMed ID: 132513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrhage into tha cavity of chronic subdural hematoma].
    Ito H; Shimoji T; Kimura M; Maeda M; Uehara S; Yamamoto S
    No Shinkei Geka; 1984 Apr; 12(5):563-8. PubMed ID: 6462354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.
    Nomura S; Kashiwagi S; Fujisawa H; Ito H; Nakamura K
    J Neurosurg; 1994 Dec; 81(6):910-3. PubMed ID: 7965121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
    Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R
    Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
    Weir B; Gordon P
    J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis in chronic subdural hematoma.
    Kawakami Y; Chikama M; Tamiya T; Shimamura Y
    Neurosurgery; 1989 Jul; 25(1):25-9. PubMed ID: 2755576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.